Krishna Institute of Medical Sciences' Q4 FY 2025-26 Quarterly Results

Result Summary

• Krishna Institute of Medical Sciences Ltd reported a 8.1% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 35.3%.
• Its expenses for the quarter were up by 9.3% QoQ and 50.6% YoY.
• The net profit decreased 36.2% QoQ and decreased 68.8% YoY.
• The earnings per share (EPS) of Krishna Institute of Medical Sciences Ltd stood at 1.06 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Krishna Institute of Medical Sciences Ltd (KIMS) is a prominent healthcare provider in India, primarily engaged in the operation and management of multi-specialty hospitals. The company offers a range of medical services, including treatment in areas such as cardiology, nephrology, gastroenterology, oncology, and more. As a healthcare institution, KIMS focuses on providing advanced medical care and maintaining high standards of clinical excellence. While specific recent developments are not available in the provided data, it is typical for such institutions to continually expand their service offerings and upgrade their facilities to meet growing healthcare demands.

Revenue

In the fourth quarter of fiscal year 2026 (Q4FY26), Krishna Institute of Medical Sciences Ltd reported a total income of ₹1084.30 crores. This represents an 8.1% increase from the previous quarter (Q3FY26), where the total income was ₹1002.90 crores. Compared to the same quarter in the previous year (Q4FY25), the total income increased by 35.3%, up from ₹801.40 crores. This year-over-year growth indicates a significant expansion in the company's revenue base over the past year, reflecting increased demand for its healthcare services.

Profitability

During Q4FY26, the company recorded a Profit Before Tax (PBT) of ₹52.20 crores, which represents a decrease of 23.9% compared to the previous quarter's PBT of ₹68.60 crores. On a year-over-year basis, this figure reflects a 61.0% decline from Q4FY25, when PBT was ₹134.00 crores. Following the application of taxes, the Profit After Tax (PAT) for Q4FY26 stood at ₹33.10 crores, down 36.2% from the preceding quarter's PAT of ₹51.90 crores. This also marks a 68.8% decrease from the PAT of ₹106.10 crores recorded in Q4FY25. The company's Earnings Per Share (EPS) also declined to ₹1.06 in Q4FY26, a reduction of 20.3% from Q3FY26 and 58.3% from Q4FY25.

Operating Metrics

Total expenses for Krishna Institute of Medical Sciences Ltd in Q4FY26 were ₹1021.20 crores, reflecting a 9.3% increase from Q3FY26, where expenses amounted to ₹934.30 crores. Year-over-year, expenses increased by 50.6%, up from ₹678.20 crores in Q4FY25. The tax expense for Q4FY26 was ₹21.70 crores, a 29.9% increase from the previous quarter's tax expense of ₹16.70 crores, yet a decrease of 22.2% compared to the tax expense of ₹27.90 crores in the same quarter last year. These figures indicate the company's cost structure and tax liabilities over the reported periods.